Clinical event rate in patients with and without left main disease undergoing isolated coronary artery bypass grafting: results from the European DuraGraft Registry
Venerdì 2 settembre 2022
circa 1 minuti di lettura
Journal and Affiliations:
European Journal of Cardio-thoracic Surgery, 2 settembre 2022
Enrico Ferrari, Cardiocentro Ticino, Lugano
Stefanos Demertzis, Cardiocentro Ticino, Lugano
Tags:
coronary artery bypass grafting
endothelial damage inhibitor
left main disease
major adverse cardiac events
Authors:
Enrico Ferrari
Stefanos Demertzis